Pharmacy Medical News

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

New Delivery System for RELISTOR in Pre-Filled Syringes Submitted for U.S. and European Marketing Approval
Wyeth, 08/06/09

Progenics Pharmaceuticals, Inc. and Wyeth Pharmaceuticals, a division of Wyeth, announced submission of a supplemental New Drug Application to the United States Food and Drug Administration and an Extension Application to the European Union European Medicines Agency for RELISTOR subcutaneous injection for a new delivery system, pre–filled syringes. RELISTOR was approved last year in single–use vials. RELISTOR is indicated for the treatment of opioid–induced constipation in patients with advanced illness who are receiving palliative care, when response to laxative therapy has been insufficient. If approved, pre–filled syringes of RELISTOR are expected to be available in the U.S. and Europe as early as the first half of 2010.

<< Previous
The Foundation for the National Institutes of Health and...

Next >>
Thrombocytopenia from Combination Treatment with Oseltamivir and...